News
Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...
Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...
To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.
In eagerly awaited results from a new study, the pharmaceutical company Eli Lilly reports that a pill its scientists ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...
Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly ...
Drugs such as Ozempic, Wegovy, and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Scholar Rock ...
12h
Vietnam Investment Review on MSNAscletis Unveils ASC47 Weight Loss Drug Candidate
ASC47 is an adipose-targeted, once-monthly subcutaneously (SQ) injected thyroid hormone receptor beta (THRβ) selective small ...
12h
TheHealthSite on MSNOzempic Side Effects: Active Ingredeints Found In Weight Loss Drugs Linked To Rare But Serious Eye Problems
A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results